Xiaolin Hou | Pharmacology | Best Researcher Award

Best Researcher Award

                 Xiaolin Hou
Affiliation Beijing University of Agriculture
Country China
Scopus ID 37045332600
Documents 61
Citations 1319
h-index 19
Subject Area Pharmacology
Event International Research Hypothesis Excellence Award
ORCID 0000-0003-4423-635X

Xiaolin Hou
Beijing University of Agriculture, China

Xiaolin Hou  the Best Researcher Award article presents an academic overview of Xiaolin Hou, a researcher affiliated with Beijing University of Agriculture, China. The profile highlights scholarly activities, publication output, and research impact indicators associated with the field of pharmacology and related interdisciplinary domains. The article further evaluates the research profile in the context of recognition through the International Research Hypothesis Excellence Award.[1]

Abstract

This article summarizes available scholarly information concerning Xiaolin Hou and evaluates academic metrics and research contributions associated with pharmacological investigations. Academic productivity indicators such as Scopus-indexed publications, citation metrics, and research visibility provide measurable evidence of scientific activity and scholarly engagement.[1]

Keywords

Pharmacology; Academic Research; Citation Analysis; Scholarly Impact; Scopus; Research Evaluation; Best Researcher Award

Introduction

Research evaluation frequently considers scientific productivity, publication quality, and measurable academic influence. Scholarly databases such as Scopus provide standardized metrics including h-index values and citation indicators for assessing research output.[2]

Research Profile

Xiaolin Hou is a professor and researcher at the College of Veterinary Medicine, Beijing University of Agriculture, China. His research focuses on veterinary pharmacology, animal disease prevention, pathogen detection, antimicrobial resistance, and viral infection mechanisms. He serves as an academic leader in Basic Veterinary Medicine and has contributed significantly to animal health and disease control research.

Research Contributions

The researcher demonstrates measurable contributions in pharmacology and scientific investigation through indexed publications and participation in academic dissemination activities. Research outcomes contribute to literature development and interdisciplinary knowledge exchange.[1]

Publications

Xiaolin Hou is a researcher and professor at Beijing University of Agriculture, China, specializing in veterinary medicine, pathogen biology, animal disease prevention, and antimicrobial research. His scholarly work includes numerous representative indexed studies available through international scientific databases, contributing significantly to veterinary pharmacology and infectious disease research.[3]

Research Impact

Citation indicators and h-index measurements are commonly employed to assess scholarly visibility and influence. Available metrics suggest substantial research engagement and dissemination within indexed academic environments.[2]

Award Suitability

The profile characteristics associated with Xiaolin Hou indicate alignment with evaluation categories commonly considered for academic distinction programs, including publication output, scholarly impact, citation metrics, and contribution to research communities.[4]

Conclusion

The presented academic profile summarizes institutional affiliation, publication metrics, and scholarly indicators associated with research productivity. Such indicators contribute to broader assessments used in academic recognition and research award programs.

References

  1. Elsevier. (n.d.). Scopus author details: Xiaolin Hou, Author ID 37045332600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=37045332600
  2. DOI Foundation. Digital Object Identifier resource.
    https://doi.org/10.1016/j.phrs.2020.104850
  3. International Research Hypothesis Excellence Award Program. Award evaluation and recognition framework.
    https://researchhypothesis.com/
  4. Shen, R., Guo, J., Liu, X., Yin, P., & Hou, X. (2026). Forsythoside A inhibits avian infectious bronchitis virus infection by binding the S1 subunit. Virology. Advance online publication.

Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award

Prof. Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award

Prof. Yun-Bae Kim | Medicine and Health Sciences | Best Researcher Award | Professor | Chungbuk National University | South Korea

Prof. Yun-Bae Kim, a distinguished professor at the Department of Toxicology, College of Veterinary Medicine, Chungbuk National University, Republic of Korea, is an eminent scholar in the fields of toxicology, neurobiology, and regenerative medicine. Holding both a Doctor of Veterinary Medicine (D.V.M.) and a Ph.D. in Veterinary Medicine from Seoul National University, Prof. Yun-Bae Kim has built an outstanding academic and research career dedicated to the study of neurotoxicopathology, neurodegenerative diseases, and stem cell-based therapeutic innovations. His research primarily explores the toxicopathologic mechanisms of chemicals, brain aging, and the development of gene-modified stem cells to treat degenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and cerebral palsy. With over 370 peer-reviewed publications and patents indexed in Scopus, PubMed, and other global databases, Prof. Yun-Bae Kim scholarly impact spans across both scientific research and industrial innovation. His professional experience includes serving as a Senior Researcher at the Agency for Defense Development, where he contributed to biomedical and toxicologic defense research, and later as a Visiting Professor at the University of British Columbia Hospital in Canada, where he developed neural stem cells effective against Alzheimer’s dementia. Prof. Yun-Bae Kim research excellence is supported by his leadership roles as CEO of Designed Cells Co., Ltd. in Korea, Vice-Chair of Qingdao Sinder Designed Stem Cells Co., Ltd. in China, Co-Chair of Designed Cells Europe D.O.O. in Croatia, and Chief Scientific Officer of ThanEver Inc. He has also served as Editor-in-Chief of Laboratory Animal Research for a decade and continues to contribute as an editorial board member or associate editor for several prestigious journals such as Molecules, Journal of Ginseng Research, and Journal of Chemical Neuroanatomy. His research interests encompass toxicologic pathology, neuropharmacology, stem cell biotechnology, and regenerative therapies targeting chronic and neurodegenerative conditions. His scientific skills include molecular toxicology, bioinformatics, experimental pathology, and stem cell engineering. Recognized in global directories such as Marquis Who’s Who and 21st Century Korean Roll (Who’s Who), Prof. Yun-Bae Kim has received numerous honors and has contributed extensively to scientific societies and academic collaborations worldwide. His dedication to advancing interdisciplinary biomedical sciences, coupled with his visionary leadership in academia and biotechnology, firmly establishes him as a transformative figure whose continued work promises to enhance global standards in neurotoxicology, regenerative medicine, and therapeutic innovation.

Profile:  Google scholar | Scopus

Featured Publications

  1. Kim, Y.-B., et al. (2024). BVN008, Diphtheria-tetanus-acellular pertussis combined vaccine has no effects on fertility and prenatal and postnatal developmental toxicity in female Sprague-Dawley rats. Reproductive Toxicology, 126, 108587. (1 citation)

  2. Kim, Y.-B., et al. (2024). The Role of Prolactin in Amniotic Membrane Regeneration: Therapeutic Potential for Premature Rupture of Membranes. Endocrinology.

  3. Kim, Y.-B., et al. (2023). Repeated Intravenous Administration of Human Neural Stem Cells Producing Choline Acetyltransferase Exerts Anti-Aging Effects in Male F344 Rats. Cells, 12(5). (2 citations)

  4. Kim, Y.-B., et al. (2023). An Exosome-Rich Conditioned Medium from Human Amniotic Membrane Stem Cells Facilitates Wound Healing via Increased Reepithelization, Collagen Synthesis, and Angiogenesis. Cells, 12(4). (12 citations)

  5. Kim, Y.-B., et al. (2023). Preventive Effects of Exosome-Rich Conditioned Medium From Amniotic Membrane-Derived Mesenchymal Stem Cells for Diabetic Retinopathy in Rats. Translational Vision Science & Technology, 12(6). (10 citations)

  6. Kim, Y.-B., et al. (2023). Effectiveness of Combinational Treatments for Alzheimer’s Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes. International Journal of Molecular Sciences, 24(9). (6 citations)

  7. Kim, Y.-B., et al. (2023). Antioxidative and Anti-Inflammatory Activities of Rosebud Extracts of Newly Crossbred Roses. Nutrients, 15(10). (3 citations).